Literature DB >> 24096893

Prevalence of human papillomavirus in anal and oral sites among patients with genital warts.

Kristian Kofoed1, Carsten Sand, Ola Forslund, Klaus Madsen.   

Abstract

Genital warts are caused by human papillomavirus (HPV). HPV is a leading cause of anogenital malignancies and a role of HPV in the aetiology of oro-pharyngeal cancers has been demonstrated. The frequency of oral HPV infection in patients with genital warts and the association between concomitant genital, anal and oral infection is unclear. A total of 201 men and women with genital wart-like lesions were recruited. Swab samples were obtained from the genital warts and the anal canal and an oral rinse was collected. Anal HPV was found in 46.2% and oral HPV in 10.4% of the participants. Concordance between anal and genital wart HPV types was 78.1%, while concordance between oral and genital wart types was 60.9%. A lower concordance of 21.7% was observed between anal and oral HPV types. Significantly more women than men had multiple HPV types and anal HPV. In conclusion, extra genital HPV is common in patients with genital warts. A gender inequality seems to exist.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24096893     DOI: 10.2340/00015555-1718

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  8 in total

1.  Concordance of Beta-papillomavirus across anogenital and oral anatomic sites of men: The HIM Study.

Authors:  Emily M Nunes; Rossana V M López; Staci L Sudenga; Tarik Gheit; Massimo Tommasino; Maria L Baggio; Silvaneide Ferreira; Lenice Galan; Roberto C Silva; Eduardo Lazcano-Ponce; Anna R Giuliano; Luisa L Villa; Laura Sichero
Journal:  Virology       Date:  2017-07-11       Impact factor: 3.616

2.  Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.

Authors:  Emmanuel Chandler; Lili Ding; Pamina Gorbach; Eduardo L Franco; Darron A Brown; Lea E Widdice; David I Bernstein; Jessica A Kahn
Journal:  J Adolesc Health       Date:  2018-07       Impact factor: 5.012

3.  Disparities by Sexual Orientation in Frequent Engagement in Cancer-Related Risk Behaviors: A 12-Year Follow-Up.

Authors:  Margaret Rosario; Fei Li; David Wypij; Andrea L Roberts; Heather L Corliss; Brittany M Charlton; A Lindsay Frazier; S Bryn Austin
Journal:  Am J Public Health       Date:  2016-01-21       Impact factor: 9.308

4.  HPV strain distribution in patients with genital warts in a female population sample.

Authors:  Daniel Boda; Monica Neagu; Carolina Constantin; Razvan Nicolae Voinescu; Constantin Caruntu; Sabina Zurac; Demetrios A Spandidos; Nikolaos Drakoulis; Dimitrios Tsoukalas; Aristides M Tsatsakis
Journal:  Oncol Lett       Date:  2016-07-22       Impact factor: 2.967

5.  Controlling Human Papilloma Virus: A Public Health Perspective of Treatment of Anogenital Warts.

Authors:  Nadeem Tanveer
Journal:  Oncologist       Date:  2017-04-04

6.  Beta and gamma human papillomaviruses in anal and genital sites among men: prevalence and determinants.

Authors:  Vitaly Smelov; Richard Muwonge; Olga Sokolova; Sandrine McKay-Chopin; Carina Eklund; Boris Komyakov; Tarik Gheit
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

7.  Anal Canal Condyloma Acuminatum Treated with Anti-HPV Biological Dressing: Clinical Analysis of 64 Cases.

Authors:  Yanyan Hu; Meihua Li; Jing Liu; Qian Huang; Jinbo Chen; Liuqing Chen; Dongsheng Li
Journal:  Indian J Dermatol       Date:  2022 Mar-Apr       Impact factor: 1.757

Review 8.  Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review).

Authors:  Daniel Boda; Anca Oana Docea; Daniela Calina; Mihaela Adriana Ilie; Constantin Caruntu; Sabina Zurac; Monica Neagu; Carolina Constantin; Daciana Elena Branisteanu; Vlad Voiculescu; Charalampos Mamoulakis; George Tzanakakis; Demetrios A Spandidos; Nikolaos Drakoulis; Aristides M Tsatsakis
Journal:  Int J Oncol       Date:  2018-01-29       Impact factor: 5.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.